Search

This new, and heavily revised, edition of Psychopharmacology, provides a comprehensive scientific study of the effects of drugs on the mind and behavior. With the growing prevalence of psychiatric and behavioral disorders and the rapid advances in the development of new drug therapies, this textbook offers an essential understanding of the necessary details of drug action. The book presents its coverage in the context of the behavioral disorders they are designed to treat, rather than by traditional drug classifications, to strengthen understanding of the underlying physiology and neurochemistry, as well as the approaches to treatment. Each disorder from the major diagnostic categories is discussed from a historical context along with diagnostic criteria and descriptions of typical cases. In addition, what we presently know about the underlying pathology of each disorder is carefully described. Providing a solid foundation in psychology, neuroanatomy and physiology, the book also offers a critical examination of drug claims, as well as coverage of evidence-based alternatives to traditional drug therapies. Throughout, this text discusses how drug effectiveness is measured in both human and animal studies. Topics new to this edition include: a stronger emphasis on the environmental impacts on drug effectiveness; more on the mechanisms of adverse reactions to drugs and information on managing drug side effects; the risks and benefits of using'mood stabilizing drugs'to address behavior in youth with ADHD or ASD; and discussion of the research-to-practice gap in pharmacological care for children and adolescents. Accompanied by a robust selection of support material, this textbook is ideal for undergraduate and pre-professional students on courses in Psychopharmacology, Clinical Psychopharmacology, Drugs and Behavior. It is a valuable contribution to highlight the symbiotic relationship between psychopharmacology and the neural and behavioral sciences.

The troubling increase in treatment resistance in psychiatry has many culprits: the rise of biomedical psychiatry and corresponding sidelining of psychodynamic and psychosocial factors; the increased emphasis on treating the symptoms rather than the person; and a greater focus on the electronic medical record rather than the patient, all of which point to a breakdown in the person-centered prescriber–patient relationship.Psychodynamic Psychopharmacology illuminates a new path forward. It examines the psychological and interpersonal mechanisms of pharmacological treatment resistance, integrating research on evidence-based prescribing processes with psychodynamic insights and skills to enhance treatment outcomes for patients who are difficult to treat.The first part of the book explores the evidence base that guides how, rather than simply what, to prescribe. It describes precisely what psychodynamic psychopharmacology is and why its emphasis on combining the often-neglected psychosocial aspects of medication with biomedical considerations provides a more optimized approach to addressing treatment resistance.Part II delves into the psychodynamics that contribute to pharmacological treatment resistance, both when patients'ambivalence about their illness, the medication itself, or their prescriber manifests in nonadherence and when medications support a negative identity or are used as replacements for healthy capacities. Readers will gain basic skills for addressing the psychological and interpersonal dynamics that underpin both scenarios and will be better positioned to ameliorate interferences with the healthy use of medications.The final section of the book offers detailed technical recommendations for addressing pharmacological treatment resistance. It tackles issues that include countertransference-driven irrational prescribing; primitive dynamics, such as splitting and projective identification; and the overlap between psychopharmacological treatment resistance and the dynamics of treatment nonadherence and nonresponse in integrated and collaborative medical care settings.By putting the individual patient back at the center of the therapeutic equation, psychodynamic psychopharmacology, as outlined in this book, offers a model that moves beyond compliance and emphasizes instead the alliance between patient and prescriber. In doing so, it empowers patients to become more active contributors in their own recovery.

Drugs, Behavior and Modern Society examines the impact of drug-taking behavior on our society and our daily lives. In order to help you understand the factors that impact drug use, author Charles Levinthal discusses the use and abuse of a wide range of licit and illicit drugs from historical, biological, psychological and sociological perspectives. This comprehensive review of psychoactive drugs is notable for the attention it pays to steroid abuse and inhalant abuse, drug-taking behaviors that are often overlooked in other texts. The 9th Edition covers recent changes in drug-taking behavior and associated social issues, including the impact of the COVID pandemic on issues relating to substance abuse and treatment.

Now in a revised and updated third edition, this noted practitioner guide and text incorporates the latest knowledge about psychopharmacology and collaborative care. Therapists and counselors learn when and how to make medication referrals and how to address patients'questions about drug benefits, side effects, safety, and more. Organized around frequently encountered mental health disorders, the book explains how medications work (including what they can and cannot accomplish). Strategies for collaborating successfully with patients, their family members, and prescribers are discussed in detail. Written for optimal practical utility, the text features case examples, sample referral letters, checklists, and a glossary. New to This Edition •Chapter on the therapeutic relationship. •New separate chapter on bipolar disorder. •Expanded discussions of distinguishing psychiatric illness from normal distress, optimizing collaboration with psychiatrists, how medications work in the brain, treatment of chronic pain, and more. •Additional case vignettes and psychopharmacology principles.

Prescribing Mental Health Medication is a comprehensive text for all practitioners who treat mental disorders with medication. This new (third) edition is fully updated and includes a variety of additional chapters.Prescribing Mental Health Medication covers the latest digital methodologies including Internet-based mental health treatment, electronic medical records and prescriber use of social media. Including information on all psychotropic medications in use in the United States and the United Kingdom, the book incorporates clinical tips, sample dialogues for talking about mental health medications to patients, and information specifically relevant in primary care settings. It looks at:• how to determine if medication is needed, proper dosing and how to start, stop and change medication • specific mental health symptoms and appropriate medication • special populations including non-adherent patients, medication abusers, those mixing alcohol and psychotropics, confused patients, children, adolescents, pregnant women and seniors • management of medication side effects and avoidance of medication risk • prescription of generic preparations• organizing a prescriptive office and record keeping.The additional chapters in this new edition of Prescribing Mental Health Medication cover topics such as combining specific medications, combining medications and psychological therapies, use of'natural'substances in mental health treatment, successfully managing patient relapse, and appropriate prescriptions of potentially controversial medications such as stimulants and benzodiazepines.This practical text explains the entire process of medication assessment, management and follow up for general medical practitioners, mental health practitioners, students, residents, prescribing nurses and others perfecting this skill.

Our remedies are only as good as the way in which we dispense themThat's the central premise of Thinking About Prescribing, a new volume that encourages pharmacotherapists to view the prescribing of a psychiatric medication to young patients not simply as part of a clinical visit, but rather as the beginning of an ongoing alliance with youth and their parents or legal guardians.The book makes the case for a partnership that doesn't lean on psychiatric jargon or an encyclopedic list of side effects, but instead on measured candor, vulnerability, and—most importantly—time.Thinking About Prescribing leverages the knowledge of more than two dozen experts as it tackles topics that include: • The essential features of the Common Factors approach and the Y-model of psychotherapy, which highlights how relational aspects of pharmacotherapy are key to child & adolescent psychiatric practice, even for brief visits• How best to utilize the 30-minute Brief Pharmacotherapy Visit (BPV), so that the alliance is nurtured and time is most efficiently utilized• Techniques, adapted from evidence-based psychotherapies, to enhance medication adherence in diverse youth populations• Approaches to adapt psychoeducation for culturally diverse populations, and consider why many youth & families may be skeptical of pharmacotherapeutic interventions• Strategies to cultivate a pharmacotherapeutic alliance when engaging with patients and families via telehealth, including in the school setting• Tips for pediatricians, advanced-practice clinicians, and other primary care providers who conduct pharmacotherapy The chapters feature key takeaways that distill the most salient points and that aid in knowledge retention.Rather than raise unrealistic expectations (two chapters acknowledge the reality of practicing when time and resources are scarce), the goal of this book is to help pharmacotherapists mitigate the stigma, apprehension, or resignation their patients may have and instead build and maintain a trusting relationship that will be key to successful therapeutic outcomes.

Algorithms serve an important purpose in the field of psychopharmacology as heuristics for avoiding the biases and cognitive lapses that are common when prescribing for many conditions whose treatment is based on complex data. Unique in the field, this title compiles twelve papers from the Psychopharmacology Algorithm Project at the Harvard South Shore Psychiatry Residency Training Program and presents practical ways to adopt evidence-based practices into the day-to-day treatment of patients. Psychopharmacology Algorithms is a useful resource for practicing psychiatrists, residents, and fellows, as well as psychiatric nurse practitioners, psychiatric physician assistants who prescribe, advanced practice pharmacists who prescribe, and primary care clinicians. Teachers of psychopharmacology may find it particularly valuable. Researchers in clinical psychopharmacology may find it helpful in identifying important practice areas that are in need of further study.

This text critically examines the shortcomings of psychiatry; the flawed development of the diagnostic system, including the DSM-5; and the failure to advance the effectiveness of antipsychotics and antidepressants. Starting with an overview of the evolution of psychiatry, Dean explores the creation, use, and misuse of medications, a process largely driven by drug companies. Other chapters describe the benefits and risks of medications, the problems associated with rational prescribing, and the embrace of so-called novel therapies including hallucinogenic drugs and opioids. Chapters end with a set of clinical notes that provide specific recommendations to clinicians, families, patients, and other providers, emphasizing the risks and benefits of treatment with medications but also stressing alternative approaches.This book will challenge clinicians to think critically about the DSM-5 and the current systems of diagnosis and treatment of mental illnesses in the hopes of ultimately improving the lives of people with mental illnesses.

What if, rather than acting only as dispensers of medication, mental health clinicians and primary care clinicians treating mental disorders were also collaborators with patients in the prescribing relationship? It's a simple but profound shift in how to think about approaching psychopharmacology, and in Prescribing Together, Warren Kinghorn and Abraham Nussbaum argue that this sort of human-to-human relationship-building is critical to prescribing more effectively and to achieving health equity.While many other books have focused on what to prescribe for given conditions, this volume is more concerned with how to prescribe: how to talk to patients about medications, how to understand the cultural and social factors that affect how both clinicians and patients relate to medication, and how to build trust in the relationship.Each chapter offers a practical introduction to at least one key concept or skill, from cultural formation and structural competency to medication concordance and deprescribing. Profiles, rich in personal anecdotes, of a diverse group of accomplished clinicians serve as an engaging, real-life foundation for evidence-based strategies for building strong alliances in the context of 13 mental disorder categories, including: • Schizophrenia• Bipolar disorder• Major depressive disorder• Generalized anxiety disorder• Neurocognitive disorders• Borderline personality disorder In drawing a contrast between a dispenser and a collaborator model, Prescribing Together encourages clinicians not just to look at their patients, but to look with them at their lived experience, to understand their stories and interpersonal and social contexts—all with the aim of returning agency to patients and empowering them to set meaningful goals and to be active particpants in their own flourishing.

Psychopharmacology: A Concise Overview, 3rd Edition is an evidence-based overview of the major classes of psychiatric medications and their use in clinical practice. Clinical considerations as to when, why, and how to use each individual medication are discussed in depth, as are relevant clinical controversies and treatment caveats. Each chapter also features an updated table of individual medications and their generic and brand names, dosing information, pertinent clinical comments, black box warnings, and Food and Drug Administration indications. This overview will equip readers with an essential framework of the concepts of psychopharmacology in an accessible length and style ideal for use as either a primer or refresher text. Medical students, residents, practicing physicians, nurse practitioners and other prescribers, as well as non-prescribing mental health clinicians who need to have a functional familiarity with available pharmacotherapies, will benefit from reading this concise book.

A defining scholarly publication on the past and current state of research with psychedelic plant substances for medicine, therapeutics, and spiritual uses.Certain plants have long been known to contain healing properties and used to treat everything from depression and addiction, to aiding in on one's own spiritual well-being for hundreds of years. Can Western medicine find new cures for human ailments by tapping into indigenous plant wisdom? And why the particular interest in the plants with psychoactive properties? These two conference volume proceedings provide an abundance of answers.The first international gathering of researchers held on this subject was in 1967, sponsored by the National Institute of Mental Health (NIMH) and U.S. Public Health Service. It was an interdisciplinary group of specialists – from ethnobotanists to neuroscientists – gathered in one place to share their findings on a topic that was gaining widespread interest: The use of psychoactive plants in indigenous societies. The WAR ON DRUGS which intervened slowed advances in this field.Research, however, has continued, and in the fifty years since that first conference, new and significant discoveries have been made. A new generation of researchers, many inspired by the giants present at that first conference, has continued to investigate the outer limits of ethno-psychopharmacology. At the same time, there has been a sea change in public and medical perceptions of psychedelics. There is now a renaissance in research, and some of these agents are actively being investigated for their therapeutic potential. They are no longer as stigmatized as they have been in the past, although they remain controversial. There still remains much work to do in this field, and many significant discoveries remain to be made.So, in June of 2017, once again specialists from around the world in fields of ethnopharmacology, chemistry, botany, and anthropology gathered to discuss their research and findings in a setting that encouraged the free and frank exchange of information and ideas on the last 50 years of research, and assess the current and possible futures for research in ethnopsychopharmacology. The papers given at the 2017 Symposium, organized by Dr. Dennis McKenna, represent perhaps the most significant body of knowledge in this interdisciplinary field available.About Dennis McKenna: He is an icon among psychedelic explorers, working to inspire the next generation of ethnobotanists in the search for new medicines for the benefit of humanity and the preservation of the biosphere that produces what is apparent from reading these papers – a rich pharmacopeia of medicines. Essential for academic libraries, pharmaceutical and ethnobotanical collections.

Most clinicians endorse the combination of pharmacotherapy and psychotherapy as more effective and beneficial than each modality alone, but combining these treatments can be a complicated and highly variable process.Competency in Combining Pharmacotherapy and Psychotherapy: Integrated and Split Treatment is designed to help psychiatrists at any stage of their career achieve competency in combining and coordinating pharmacotherapeutic and psychotherapeutic treatments for the benefit of their patients.This guide, now in its updated, second edition, addresses both integrated (single clinician) and split/collaborative (multiple clinicians) treatments, discussing for each: • The selection of medication and psychotherapy• The patient evaluation and opening• Sequencing• Evaluating, monitoring, and supervising treatment• Terminating and transitioning patient care The book also offers a chapter -- new to this second edition -- that focuses on primary care access for mental health services in the context of integrated and split/collaborative care.The rapid transformation of clinical care models in new health systems means that competence in integrated and split/collaborative care is absolutely vital for long-established clinicians as well as for psychiatric professionals in the early stages of their careers.Competency in Combining Pharmacotherapy and Psychotherapy offers an unrivaled introduction to the complex process of combining medication and psychosocial treatments, clearly defining the competencies of combining two modalities. Psychiatric educators should note that this resource relates to all six main competencies of the Accreditation Council for Graduate Medical Education: patient care and procedural skills, medical knowledge, practice-based learning and improvement, interpersonal and communication skills, professionalism, and systems-based practice.

The explosive story of the discovery and development of psychiatric medications, as well as the science and the people behind their invention, told by a riveting writer and psychologist who shares her own experience with the highs and lows of psychiatric drugs. Although one in five Americans now takes at least one psychotropic drug, the fact remains that nearly seventy years after doctors first began prescribing them, not even their creators understand exactly how or why these drugs work -- or don't work -- on what ails our brains. Lauren Slater's revelatory account charts psychiatry's journey from its earliest drugs, Thorazine and lithium, up through Prozac and other major antidepressants of the present. Blue Dreams also chronicles experimental treatments involving Ecstasy, magic mushrooms, the most cutting-edge memory drugs, placebos, and even neural implants. In her thorough analysis of each treatment, Slater asks three fundamental questions: how was the drug born, how does it work (or fail to work), and what does it reveal about the ailments it is meant to treat? Fearlessly weaving her own intimate experiences into comprehensive and wide-ranging research, Slater narrates a personal history of psychiatry itself. In the process, her powerful and groundbreaking exploration casts modern psychiatry's ubiquitous wonder drugs in a new light, revealing their ability to heal us or hurt us, and proving an indispensable resource not only for those with a psychotropic prescription but for anyone who hopes to understand the limits of what we know about the human brain and the possibilities for future treatments.

This jargon-free guide is suitable for all trainee and registered health professionals who require knowledge and understanding of drugs used in the treatment of mental health conditions for prescribing or administering purposes. A life-saving pocketbook that you can easily carry anywhere you go! Introductory material provides a background on psychotropic drugs, the etiology of mental illness, some of the commonly used drugs in practice and brief notes on common non-pharmacological interventional options. It also examines biochemical and neurodevelopmental theories and the link to the pathophysiology of mental illness as well as clinical decision making. The central chapters of the book provide comprehensive coverage of all the major medications used in mental health. Each focuses on a specific class of drug, detailing the most commonly used medicines, including side effects, average doses, contra-indications and clinical management interventions that may be required. At the end of each chapter a series of review questions enable readers to review their learning, and theory is clearly related to practice throughout.

With increases in the prevalence of psychiatric and behavioral disorders and rapid advances in the development of new drug therapies, there is an increasing need to present the science behind these developments. Students and educators are often confronted with conflicting and exaggerated claims about the effectiveness of drugs. As recently as ten years ago, the mechanisms of action of many medications prescribed for common psychological disorders were not well understood, even by the scientists developing them. Now, drug treatment has advanced to a stage where drugs are designed for their effects on specific receptors, membrane proteins, or secondary messengers within particular cells in the brain. This text introduces a sufficient background in neuroanatomy and physiology so students can comprehend the necessary details of drug action. Psychopharmacology, Second Edition, presents its subject matter in the context of the behavioral disorders they are designed to treat, rather than by traditional drug classifications. Students are often familiar with the major diagnostic categories, so presenting psychopharmacology as it pertains to these familiar disorders strengthens their understanding of the physiology and neurochemistry underlying them as well as the approaches to their treatment. Each disorder is discussed from a historical context along with diagnostic criteria and descriptions of typical cases. In addition, what we presently know about the underlying pathology of each disorder is carefully described. A critical examination of drug claims is missing from most psychopharmacology texts, but is offered here. Students will read about the most current research available from a critical perspective. When alternatives to traditional drug therapies are supported by research, these studies are presented as well. Throughout, this text discusses how drug effectiveness is measured in both human and animal studies. Psychopharmacology has contributed significantly over the past 75 years to the treatment of severe psychological disorders as well as to our understanding of the brain and human behavior. This symbiotic relationship between psychopharmacology and the neural and behavioral sciences will continue long into the future. This fully updated second edition is ideal for undergraduate and pre-professional students, and includes a robust companion website.

This is the definitive guide and desk reference for healthcare professionals and patients to expand their knowledge in the pharmacological and behavioral treatment of psychosis, anxiety, depression, bipolar, insomnia and ADHD.New to the third edition: DSM-5® and psychotropic medication prescribing New risk factors with antidepressants Anxiety treatment — what should not be medicated Herbal and other alternative treatments Latest in geriatric psychopharmacology Psychotropic medication discontinuation-safe strategies that work Additive and combination medication protocols Newly released psychiatric medications Dosage Range Charts

Essentials of Psychopharmacology provides a synopsis and update of the most clinically relevant material included within its parent publication, The American Psychiatric Publishing Textbook of Psychopharmacology, a classic that has been hailed as indispensable to psychiatry residents and clinicians alike. This new third edition of the Essentials incorporates the latest research and treatment advances and presents key information in an accessible and easy-to-use manner. The chapter authors are among the foremost national authorities in their areas of expertise, and the content has been thoroughly referenced and meticulously edited for maximum utility. Among the features of this third edition are the following: • Commonsense organization that takes the reader through the various classes of psychotropic medications (with chapters focused on individual drugs in each class) to treatment using those drugs (with chapters addressing drug selection and therapeutic approaches to the treatment of patients with major psychiatric disorders).• Complete information on each drug's clinical pharmacology, pharmacokinetics, approved indications, dosages, side effects and toxicology, and drug-drug interactions.• Comprehensive coverage of the current psychotropic pharmacopoeia, including new chapters on the recently introduced antipsychotics asenapine, iloperidone, and lurasidone and updated chapters reflecting further accumulation of experience with other medications.• Extensive and thoroughly updated information on the use of psychotropic medications during pregnancy and lactation. Clinicians seeking a reliable reference and guide to the core knowledge base and practice of clinical psychopharmacology can do no better than this new edition of Essentials of Psychopharmacology.

Manual of Clinical Psychopharmacology for Nurses offers a holistic approach to psychopharmacological prescribing from a nursing perspective and is the only text designed especially for Psychiatric Mental Health Advanced Practice Registered Nurses (P.M.H.-A.P.R.N.s). The Manual is grounded in the belief that given their nursing background and their personalized approach to the individual, P.M.H.-A.P.R.N.s are uniquely qualified to offer symptom-based treatment within the context of an individual's medical and psychological care. A comprehensive resource for advanced practice nurses, mental health practitioners, general practitioners, and consumers, this book possesses many useful features, including the following: • A logical, easy-to-use format that guides the reader through the most common psychiatric conditions, presenting the diagnostic criteria and neurobiology of the relevant disorder, pharmacological choices and recommendations on monitoring, side effects to consider, and treatment of special populations, including those with medical illnesses.• A special chapter devoted to culturally sensitive psychopharmacology that offers information on the role of culture in mental health, wellness, and illness and provides culturally sensitive assessment techniques and other treatment strategies PMH nurses can use to minimize stigma; address health care disparities; and improve patient adherence, satisfaction, and outcomes.• A chapter that addresses complementary and alternative pharmacotherapies -- vital because a significant percentage of patients may be using herbal preparations, which present serious implications for the prescribing clinician.• Appendices covering drug dosing equivalencies, pharmacogenetics, psychiatric rating scales, and other helpful resources. The core philosophy of the advanced practice nursing field is that health care should be individualized, focusing not only on patients'conditions but also on the effects those conditions have on patients'lives and the lives of their families. The Manual of Clinical Psychopharmacology for Nurses offers readers the most current information on psychopharmacological treatment in an accessible, easy-to-use format grounded in the principles and practices of holistic nursing.

This book aims to provide comprehensive, up-to-date information on psychotropic drugs and inform clinical decisions for the treatment of mental disorders using a problem-solving approach.In order to accomplish these goals, the book has three central characteristics:More than a textbook, it is meant to serve as a practical tool for professionals working in the mental health field.

De behandeling van psychiatrische stoornissen bij kinderen en jeugdigen heeft de afgelopen jaren een grote vlucht genomen en daarbij wordt in toenemende mate gebruik gemaakt van psychofarmaca. Het grootste deel daarvan is?slechts? getest en goedgekeurd voor gebruik bij volwassenen. Daar komt nog bij dat de langetermijneffecten van dit type medicijnen op het centraal zenuwstelsel nog onvoldoende bekend zijn. Een grote mate van zorgvuldigheid bij het voorschrijven van deze vorm van medicatie aan kinderen is dus geboden. Een goed hulp­middel daarbij vormt dit formularium voor de kinder- en jeugd­psychiatrische praktijk.'Psychofarmaca in de KJP'biedt the state of the art als het gaat om de kennis op het gebied van het gebruik van psychofarmaca bij kinderen en jeugdigen en sluit daarmee aan op de eveneens bij Koninklijke Van Gorcum verschenen KJP-trilogie onder ­redactie van Fop Verheij, Frank Verhulst en Robert Ferdinand. Het gaat bij deze uitgave nadrukkelijk om richtlijnen. Bij het opstellen ervan hebben betrokkenen zich steeds laten leiden door'best available evidence'.

An excellent addition to current resources in psychopharmacology for graduate and postgraduate trainees in psychiatry, neurology, medicine, pharmacy and pharmacology. A comprehensive series of relevant questions and an extensive bibliography that will be both a useful test of trainees'progress and also a useful aide memoire and primer. Consists of 2600 questions in the form of ‘True/False Individual Statements, Extended Matching Items and Best of Five'formats, organised in 52 papers in two volumes

A comprehensive yet practical guide to the prescription of psychotropic medications in patients with medical illness, Clinical Manual of Psychopharmacology in the Medically Ill is designed to be useful to clinicians practicing in a broad range of specialties, from the psychosomatic medicine specialist caring for a delirious patient with cancer to the general medical practitioner prescribing an antidepressant to a diabetic patient who recently had a myocardial infarction. This manual • Provides useful psychotropic prescribing protocols that can be employed by primary care physicians, psychiatrists, and other medical professionals.• Reviews fundamental principles of psychotropic drug prescribing across medical specialties.• Educates clinicians regarding the growing evidence base supporting the safety and efficacy of psychopharmacological treatments for a diverse range of psychiatric problems in medically ill patients.• Provides clinically relevant information concerning psychopharmacology in the medically ill, including pharmacokinetic and pharmacodynamic principles, drug-drug interactions, and organ system disease-specific issues. Clinical Manual of Psychopharmacology in the Medically Ill is divided into two sections. The first supplies fundamental background information for prescribing psychotropics across medical disease states, including discussion of pharmacodynamics and pharmacokinetics, drug-drug interaction principles, major systemic adverse effects of psychotropic drugs, and alternate routes of psychotropic drug administration. The second section addresses psychopharmacological treatment in specific organ system diseases, such as renal and cardiovascular disease, as well as other relevant subspecialty areas, such as critical care, organ transplantation, pain, and substance use disorders. Authored by experts in the field, chapters contain the following: • Key differential diagnostic considerations, including adverse neuropsychiatric side effects of disease-specific medications• Disease-specific pharmacokinetic principles in drug prescribing, including interactions between psychotropic drugs and disease-specific drugs• Useful tables summarizing information on adverse neuropsychiatric side effects of disease-specific medications, adverse disease-specific side effects of psychotropic drugs, and drug-drug interactions• Extensive referencing of source material to allow readers to expand their knowledge in specific areas This manual, beyond serving as a clinical guide, should become a mainstay of curricula in general psychiatric residency programs, psychosomatic medicine fellowships, and nonpsychiatric residency training programs that prepare physicians to provide safe and effective psychopharmacological treatment for patients with medical illness.

This indispensable book provides therapists and counselors with crucial knowledge about psychotropic medications: when and how to make medication referrals, how to answer patients'questions and help them handle problems that arise, and how to combine medication and psychotherapy effectively. Ideal for readers without extensive background in neurobiology, the book clearly explains how medications work in the brain and how they affect an individual's emotions, behavior, and relationships. Strategies for collaborating successfully with patients, their family members, and prescribers are discussed in detail. In this edition, psychopharmacology content has been fully updated.

Introduction to Neuropsychopharmacology expands on the molecular and cellular foundations of the classic Biochemical Basis of Neuropharmacology, Eighth Edition (Cooper, Bloom, and Roth) by now including the behavioral methods used to study psychoactive drugs in experimental animals and in humans. Authored by four founders of modern neuroscience, this concise and comprehensive text covers the current series of medications used to treat diseases of the brain and nervous system--both psychiatric and neurologic--as well as legal and illegal recreational drugs and the neuroscientific information that explains how these medications act on the brain from the molecular to the clinical level. The text ranges from drugs that affect the mood and behavior to hypnotics, narcotics, anticonvulsants, and analgesics.

Psychotropic agents have been effective for the treatment of the emotional, and cognitive symptoms of serious psychiatric disorders. At the same time, the availability of such agents raises questions about the appropriate use of what might be termed'smart pills','happy pills', or'pep pills'. This volume argues that developments in modern psychopharmacology raise a range of important philosophical questions, and may ultimately change the way we think about ourselves. It provides a framework for addressing important philosophical issues in psychiatry and psychopharmacology. The approach is a naturalistic one, drawing on theory and data from modern cognitive-affective neuroscience and attempts to address objective and subjective aspects of psychiatric disorders, to integrate our knowledge of mechanisms and meanings, and to provide a balanced view of the good and the bad of psychotropics.

No one reacts or responds to a drug in exactly the same way, just as no two persons are exactly alike. Individual and ethnic differences in drug response have been consistently found in clinical practice. This book covers all the important factors that explain how and why drug treatments used in psychiatry affect individuals and ethnic groups differently. It will increase understanding of how biological differences interact with social, cultural and environmental factors to bring about overall effects of medications, particularly in individuals from various ethnicities. This book uniquely brings these varied aspects together to consider a holistic approach to drug therapy across diverse biological make-up and cultures. This information has direct practical use in the clinical setting.

Provides knowledge about psychotropic medications: when and how to make medication referrals, how to help patients handle questions and problems that arise, and how to combine medication and psychotherapy effectively. This book explains how medications work in the brain and how they affect an individual's emotions, behavior, and relationships.

Why are some drugs highly addictive? What exactly are the effects of different types of psychoactive drugs? How can they produce such dramatic effects on mood, cognition, sensation, awareness, health and well-being?. Understanding Drugs and Behaviour describes in detail how the main psychoactive drugs can alter brain chemistry and modify behaviour. Written by experienced lecturers with a high level of research expertise, all the main drugs used in today's society are included, such as alcohol, nicotine, cannabis, LSD and Ecstasy, opiates, CNS stimulants, as well as clinical medications. Teach.

Prescribing Mental Health Medication is a text for nursing and medical practitioners who are learning how to diagnose and treat mental disorders with medication. Skills-based, it focuses on the following key issues:how to start a

Why do smokers claim that the first cigarette of the day is the best? What is the biological basis behind some heavy drinkers'belief that the'hair-of-the-dog'method alleviates the effects of a hangover? Why does marijuana seem to affect ones problem-solving capacity? Intoxicating Minds is, in the author's words,'a grand excavation of drug myth.'Neither extolling nor condemning drug use, it is a story of scientific and artistic achievement, war and greed, empires and religions, and lessons for the future. Ciaran Regan looks at each class of drugs, describing the historical evolution of their use, explaining how they work within the brain's neurophysiology, and outlining the basic pharmacology of those substances. From a consideration of the effect of stimulants, such as caffeine and nicotine, and the reasons and consequences of their sudden popularity in the seventeenth century, the book moves to a discussion of more modern stimulants, such as cocaine and ecstasy. In addition, Regan explains how we process memory, the nature of thought disorders, and therapies for treating depression and schizophrenia. Regan then considers psychedelic drugs and their perceived mystical properties and traces the history of placebos to ancient civilizations. Finally, Intoxicating Minds considers the physical consequences of our co-evolution with drugs—how they have altered our very being—and offers a glimpse of the brave new world of drug therapies.

There are hundreds, if not thousands, of substances that are used to modify behavior. While different classes of substances have known effects, one has only to see a group of people drinking to excess to recognize that not everyone responds in the same way to a given substance. Why do substances have the behavioral effects they do, and why do individuals vary in their responses to them? This book provides a conceptual framework for answering such questions.Introduction to Behavioral Pharmacology includes a short overview of behavioral analysis and general pharmacology, followed by detailed discussion of assessment of drug effects, the stimulus properties of drugs, drug abuse, and more.

Ethnicity and Psychopharmacology addresses the most relevant theoretical and clinical aspects of ethnopsychopharmacology, with the aim of advancing this growing field well into the twenty-first century. Detailed are the pharmacogenetic, pharmacokinetic, and pharmacodynamic mechanisms involved in differing responses to drug treatment among various ethnic groups living in the United States. Readers will learn an integrative approach in which ethnic and cultural diversity and biological diversity are taken into account and treatment is tailored to specific individual characteristics.Dr. Ruiz's extensive research experience and years of leadership in public psychiatry along with his distinguished panel of contributors combine to make this book an authoritative resource. Psychiatric practitioners, educators, and investigators, as well as other mental health professionals, primary care physicians and medical students, will gain a better understanding of treating patients from different cultures.

A psychopharmacologist should be aware of the functions of the brain, understands the biological basis of various mental disorders, study the pharmacology of various psychoactive agents, and finally familiarizes himself with the treatment of these disorders. With this broad scope, the book is written in four parts. The first part includes nerve transduction, dopaminergic serotonergic and norepinephrinergic system and pharmacokinetics. The second part deals with the pharmacology of various drugs. The third part explores the psychobiology of various mental disorders and the last part provides detailed information on the treatment of various mental disorders. Treatment of special populations are also included in the last part.

Psychopharmacological Agents, Volume IV summarizes the chemistry, pharmacology, and clinical manifestations of psychoactive drugs which are abused, with emphasis on opiate abuse and its treatment. The historical, legal, regulatory, and sociological aspects of the abuse of central nervous system agents are described, along with the treatment modalities that have evolved from some of these afflictions. Comprised of six chapters, this volume begins with an introduction to drug abuse and drug dependence, followed by a discussion on various perspectives in drug abuse and modalities for treating patients who are dependent on opiates. Studies on non-abusive analgetics such as opium compounds are then reviewed, together with the chemistry, mechanism of action, and medical applications of psychotomimetic drugs. The final two chapters deal with the treatment of opiate abuse by methadone maintenance and the regulatory aspects of drug abuse. This book will be of interest to students, practitioners, and researchers in medicinal chemistry, psychology, and pharmacology.